《港股》恆指半日跌107點 藥股及金股回吐 內房股造好
美國將向各國通知對等關稅稅率,8月生效。市場繼續觀望美國關稅談判,港股早市偏軟。恆指低開87點,初段跌202點低見23,713點,其後跌幅收窄至52點報23,863點,半日跌107點或0.4%,報23,808點;國指跌37點或0.4%,報8,571點;恆生科技指數跌7點或0.2%,報5,208點。大市半日成交總額1,095.07億元。
小米交付YU7,小米(01810.HK)跌近1%報56.95元。市場關注中歐電動車談判,比亞迪(01211.HK)升0.1%報121.6元,小鵬(09868.HK)升1.6%。電池股寧德時代(03750.HK)跌1.6%報351.2元。
美團發放大量外賣紅包券,即時零售日訂單突破1.2億單,美團(03690.HK)跌2.4%,京東(09618.HK)升0.3%,阿里(09988.HK)跌0.3%報104.8元。百度視頻生成模型MuseSteamer發布,百度(09888.HK)升0.2%。其他科技股方面,騰訊(00700.HK)及嗶哩嗶哩(09626.HK)升0.7%及0.5%,快手(01024.HK)升1.5%,網易(09999.HK)跌0.5%,中芯(00981.HK)升0.2%。此外,比亞迪電子(00285.HK)跌2.8%,金軟(03888.HK)及金蝶(00268.HK)跌3.3%及4.2%,萬國數據(09698.HK)跌5.9%。
金融股方面,匯控(00005.HK)升0.5%,渣打(02888.HK)升2.6%,港交所(00388.HK)及友邦(01299.HK)及1.6%及1.4%。國泰君安國際(01788.HK)半日升8.2%,成交33.79億元。眾安在線(06060.HK)升5.6%。
富衛(01828.HK)首日掛牌半日收38.4元,較上市價38元高1.1%。內房股融創(01918.HK)及新城(01030.HK)升3.9%,潤地(01109.HK)及綠城(03900.HK)升3.4%及3.1%。
金價電子交易時段偏軟,中國黃金國際(02099.HK)跌3.2%,山東黃金(01787.HK)及招金(01818.HK)跌逾5%。其他股份方面,中國飛鶴(06186.HK)發盈警,預計中期淨利潤下跌,股價瀉17.4%。維他奶(00345.HK)炒高7.1%報9.91元。濠賭股澳博(00880.HK)及金沙中國(01928.HK)升4.2%及2.7%。醫藥股信達生物(01801.HK)及藥明生物(02269.HK)跌4.2%及5.7%,榮昌生物(09995.HK)跌6.9%。光伏相關股福萊特玻璃(06865.HK)及新特能源(01799.HK)跌3.4%,信義光能(00968.HK)跌4.2%。
健康之路(02587.HK)升10.2%,成交11.24億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.